Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccineChangrui Lu(Donghua University), Xiaoming Yang(China National Biotechnology (China))bioRxiv (Cold Spring Harbor Laboratory)September 6, 202210.1101/2022.09.06.506714Cited by 1SaveCiteExport RISWatch citationsRelated PapersHeterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine|Antiviral Research|2023|10In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor Agents|Molecules|2023|3